Cencora (COR) 8-K Other Events

Exhibit 99.1

AmerisourceBergen Corporation

Unaudited Summary Segment Information

(dollars in thousands)

	Three Months Ended December 31,							Three Months Ended March 31,							Three Months Ended June 30,
Revenue	2011			2010			Change	2012			2011			Change	2012			2011			Change
Pharmaceutical Distribution	$	20,134,050		$	19,778,084		2%	$	19,757,210		$	19,652,364		1%	$	19,372,722		$	20,036,062		(3)%
Other	258,061			120,398			114%	357,696			122,520			192%	453,701			140,100			224%
Intersegment eliminations	(31,466		)	(9,873		)	219%	(43,635		)	(14,627		)	198%	(57,039		)	(15,140		)	277%
Revenue	$	20,360,645		$	19,888,609		2%	$	20,071,271		$	19,760,257		2%	$	19,769,384		$	20,161,022		(2)%

	Three Months Ended December 31,						Three Months Ended March 31,						Three Months Ended June 30,
Operating Income	2011			2010		Change	2012			2011		Change	2012			2011		Change
Pharmaceutical Distribution	$	276,385		$	268,148	3%	$	350,021		$	346,894	1%	$	295,296		$	304,877	(3)%
Other	12,088			8,618		40%	27,107			18,355		48%	23,243			12,282		89%
Employee severance, litigation and other	(3,559		)	—		N/M	(9,027		)	—		N/M	(4,844		)	—		N/M
Operating income	$	284,914		$	276,766	3%	$	368,101		$	365,249	1%	$	313,695		$	317,159	(1)%
Percentages of revenue:
Pharmaceutical Distribution
Gross profit	2.74%			2.78%			3.22%			3.30%			3.06%			3.08%
Operating expenses	1.37%			1.43%			1.44%			1.53%			1.53%			1.56%
Operating income	1.37%			1.36%			1.77%			1.77%			1.52%			1.52%
Other
Gross profit	15.67%			24.49%			16.70%			32.42%			21.30%			25.65%
Operating expenses	10.98%			17.34%			9.12%			17.44%			16.18%			16.88%
Operating income	4.68%			7.16%			7.58%			14.98%			5.12%			8.77%
AmerisourceBergen Corporation
Gross profit	2.91%			2.92%			3.46%			3.48%			3.49%			3.24%
Operating expenses	1.51%			1.53%			1.63%			1.63%			1.90%			1.67%
Operating income	1.40%			1.39%			1.83%			1.85%			1.59%			1.57%